Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

BACKGROUND-: Data exist that demonstrate isoflavones' potent antiproliferative effects on prostate cancer cells. We evaluated the efficacy of isoflavone in patients with PSA recurrent prostate cancer after prior therapy. We postulated that isoflavone therapy would slow the rate of rise of serum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pendleton, John M, Tan, Winston W, Anai, Satoshi, Chang, Myron, Hou, Wei, Shiverick, Kathleen T, Rosser, Charles J
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394534/
https://ncbi.nlm.nih.gov/pubmed/18471323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-132
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados